FDA Inspection 943082 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3002808311

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on September 18, 2015 in Yodogawa-Ku. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 18, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yodogawa-Ku (Japan)